Categories: BrainNews

Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System

WOODBRIDGE, N.J., July 24, 2024 /PRNewswire/ — Soterix Medical Inc., the global leader in stimulation and synergistic monitoring technologies, announced today it has received a 510(k) clearance from the U.S. Food & Drug Administration for its Intraoperative Neurophysiologic Monitoring (IOM) system, MEGA-IOM. The system provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk and improve surgical outcomes. ­It includes preset modalities such as motor evoked potentials (MEP) to evaluate the integrity of motor pathways, somatosensory evoked potentials (SSEP) to evaluate the integrity of sensory pathways and detect brain and spinal cord ischemia, EEG to record and analyze brain activity (functional state of the brain), and direct stimulation to control the functional integrity of peripheral nerves.

MEGA-IOM provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk.

“This FDA authorization represents a significant milestone for our organization as we can now offer the MEGA-IOM system to surgical teams across the U.S.,” said Ms. Danielle Dadona, VP of Regulatory Affairs of Soterix Medical. “This U.S. manufactured system pairs with an intuitive, rich, software interface with exceptional usability.”

Mr. Kamran Nazim, Chief Product Officer of Soterix Medical commented “MEGA-IOM is a cutting-edge modular platform solution that combines years of knowledge and experience obtained in clinical and research environments. Due to flexible channel configuration and size options (cart-based or portable), the system can meet the most exacting needs of both surgeons and advanced neuromonitoring specialists.”

Surgeons, neurophysiologists, neurologists and intraoperative monitoring service companies in the United States interested in incorporating the MEGA-IOM system are eligible for Soterix Medical’s Partnership program which includes support on the entire system, hands-on training and staff certification. Interested parties should contact Soterix Medical (at contact@soterixmedical.com) for additional information.

Media Contact: Chaya Edelman
Tel: +1-888-990-8327
Email: contact@soterixmedical.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/soterix-medical-announces-fda-510k-clearance-of-mega-iom-intraoperative-neuromonitoring-system-302204284.html

SOURCE Soterix Medical, Inc.

Staff

Recent Posts

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

3 hours ago

Clemson University and Nordic Wellness Launch Groundbreaking Partnership to Transform the Student Mental Health Crisis

Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health…

3 hours ago

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF)…

3 hours ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”)…

3 hours ago

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

18 hours ago